Drug class
Propionic-acid non-steroidal anti-inflammatory drug (NSAID); ophthalmic cyclooxygenase inhibitor
Mechanism of action
Inhibits cyclooxygenase-mediated prostaglandin synthesis, reducing ocular inflammation, pain and inflammatory miosis. Topical ophthalmic administration produces local anti-inflammatory effects.
General use cases
- Treatment of postoperative ocular inflammation and pain, and selected inflammatory eye conditions such as conjunctivitis or blepharitis, according to local product authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
